Cargando…
Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy
Duchenne Muscular Dystrophy is characterized by: near absence of dystrophin in skeletal muscles; low percentage of revertant myofibers; up-regulation of utrophin synthesis; and a high degree of muscle fibrosis. In patient quadriceps femoris biopsies (n = 6, ages between 3–9 years) an inverse correla...
Autores principales: | Levi, Oshrat, Genin, Olga, Angelini, Corrado, Halevy, Orna, Pines, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695115/ https://www.ncbi.nlm.nih.gov/pubmed/26015394 |
Ejemplares similares
-
Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy
por: Mordechay, Sharon, et al.
Publicado: (2021) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019) -
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
por: Soblechero‐Martín, Patricia, et al.
Publicado: (2021) -
Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening
por: Moorwood, Catherine, et al.
Publicado: (2011) -
Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells
por: Sengupta, Kasturi, et al.
Publicado: (2020)